Wan-Yu (Wendy) Chu

Employment

• Uppsala universitet Postdoctoral researcher
  2025 - Present
• The Netherlands Cancer Institute Phd student
  2021 - 2025

Education

• Utrecht University MSc.

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post‐Kala‐Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing
  Wan‐Yu Chu, Om Prakash Singh, Shyam Sundar +10 more
  Clinical Pharmacology & Therapeutics 2026 DOI: 10.1002/cpt.70124
  +Save
• Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole, and Hydroxyitraconazole in Sudanese Patients With Eumycetoma
  The Journal of Infectious Diseases 2025 DOI: 10.1093/infdis/jiaf279
  +Save
• Disease-Specific Differences in Pharmacokinetics of Paromomycin and Miltefosine Between Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Patients in Eastern Africa
  The Journal of Infectious Diseases 2024 DOI: 10.1093/infdis/jiae413
  +Save
• Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia
  Journal of Antimicrobial Chemotherapy 2024 DOI: 10.1093/jac/dkae129
  +Save
• Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis
  Journal of Antimicrobial Chemotherapy 2023 DOI: 10.1093/jac/dkad286
  +Save
• Pyronaridine: a review of its clinical pharmacology in the treatment of malaria
  Journal of Antimicrobial Chemotherapy 2023 DOI: 10.1093/jac/dkad260
  +Save
• Comment on “Dosing implications for liposomal amphotericin B in pregnancy”
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2023 DOI: 10.1002/phar.2862
  +Save